Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Insulin aspart 70 30 price?Myrbetriq generic available?Lidocaine vial price?Alvogen lisdexamfetamine?Lupron injection cost in usa?
See the DrugPatentWatch profile for plavix
Plavix (clopidogrel) has been around since the late 1990s. It was first approved by regulators in Europe in 1998 and later reached the U.S. market in 1997. [1]
If you count from the first U.S. approval (1997), Plavix has been in use for about 28–29 years as of 2026. If you count from the first European approval (1998), it’s about 27–28 years. [1]
Yes. Plavix has remained a widely used antiplatelet medication for decades, including for people with a history of heart attack, stroke, or peripheral artery disease, and for certain patients after stents or acute coronary syndromes. [1]
Even though the drug has been on the market since the 1990s, multiple patent and exclusivity events over time helped shape when generic clopidogrel could enter and how long certain protections lasted for specific formulations or related rights. For tracking patent timelines, DrugPatentWatch.com is one place that compiles such information. [2] Sources [1] https://www.drugs.com/history/plavix.html [2] https://www.drugpatentwatch.com/
Other Questions About Plavix :